Inactief instrument

Andere talen GX ACQU Nasdaq

Aandelen

GXGXU

US36251A2069

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

GX Acquisition : Clinical pipeline includes multiple clinical stage programs including acute myeloid leukemia (AML) and glioblastoma multiforme (GBM), with a total of five clinical programs expected by 1H 2022 (Form 8-K)	22-07-21
Celularity Closes Merger With GX Acquisition Corp	16-07-21
Celularity Inc. completed the acquisition of GX Acquisition Corp. in a reverse merger transaction.	16-07-21
GX Acquisition : Submission of Matters to a Vote of Security Holders (Form 8-K)	15-07-21
GX Acquisition Corp. Approves Elections of Nine Directors	15-07-21
GX ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders (form 8-K)	15-07-21
GX Acquisition Corp.(NasdaqCM:GXGX) dropped from NASDAQ Composite Index	15-07-21
GX Acquisition : Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States (Form 8-K)	02-07-21
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	01-07-21
GX Acquisition : Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) Phase 1 Trial in Patients with Acute Myeloid Leukemia (Form 8-K)	29-06-21
GX ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	29-06-21
GX ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	24-05-21
Gx Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	24-05-21
GX ACQUISITION : 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	24-05-21
GX ACQUISITION CORP. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14-05-21
GX Acquisition Corp. : Announces Shareholder Approval of Extension Proposal	14-05-21
GX Acquisition : Announces Additional Contributions to Trust Account (Form 8-K)	12-05-21
GX ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)	10-05-21
GX Acquisition Corp. : Announces Additional Contributions to Trust Account	10-05-21
GX Acquisition : Celularity to leverage Palantir’s next generation software and computational capabilities with their deep cellular data set to accelerate research and development activities	06-05-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen GX ACQU Nasdaq

Aandelen

GXGXU

US36251A2069

Andere talen

Filters